切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2024, Vol. 14 ›› Issue (01) : 90 -92. doi: 10.3877/cma.j.issn.2095-2015.2024.01.016

短篇论著

以解剖部分肝为核心的精准手术治疗肝细胞癌的效果分析
束长新1,(), 王国峰1   
  1. 1. 225200 江苏省,扬州大学医学院附属扬州友好医院普外科
  • 收稿日期:2023-08-26 出版日期:2024-02-01
  • 通信作者: 束长新
  • Received:2023-08-26 Published:2024-02-01
引用本文:

束长新, 王国峰. 以解剖部分肝为核心的精准手术治疗肝细胞癌的效果分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 90-92.

肝细胞癌是一种发病率较高的临床疾病,手术是主要的治疗方式之一。精准肝胆外科手术以解剖部分肝为核心基础,实现对肿瘤局部的精确切除和有效治疗,是肝细胞癌的重要治疗手段,具有显著的疗效和预后价值[1,2]。这种手术可以根据肿瘤的位置、大小和侵犯范围,制定个体化的手术方案,最大程度地保留正常肝组织,同时彻底切除肿瘤组织,达到最佳的治疗效果[3,4]。此外,精准肝胆外科手术还可以辅以其他治疗方式,如术前或术后放化疗、靶向治疗等。综合应用多种治疗手段,可以有效控制肿瘤的生长和扩散,提高患者的生存率和生活质量[5,6]。基于此,选择120例肝细胞癌患者进行回顾研究,对以解剖部分肝为核心基础的精准肝胆外科手术的可行性价值进行分析。

表1 两组治疗时间指标比较(±s
表2 两组手术并发症比较[例(%)]
表3 两组治疗满意度比较[例(%)]
[1]
汪鑫, 张洪义. 肝恶性肿瘤精准外科手术治疗确定[J]. 中国临床医生杂志, 2022, 50(5): 516-520.
[2]
Attal N, Sullivan MT, Girardi CA, et al. Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression[J]. Transl Oncol, 2021, 14(1): 75-78.
[3]
Peng JM, Tseng RH, Shih TC, et al. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling[J]. Cancer Lett, 2021, 20(2): 497-497.
[4]
Wang Q, Guan X, Lai C, et al. Selenium enrichment improves anti-proliferative effect of oolong tea extract on human hepatoma HuH-7 cells[J]. Food Chem Toxicol, 2021, 147: 111873.
[5]
袁声贤, 周伟平. 肝脏切除术后少见并发症的诊断和防治[J]. 肝胆外科杂志, 2021, 29(4): 251-253.
[6]
Song XJ, Zhang L, Li Q, et al. hUCB-MSC derived exosomal miR-124 promotes rat liver regeneration after partial hepatectomy via downregulating Foxg1[J]. Life Sci, 2021, 12(9): 265-265.
[7]
Gerratana L, Davis AA, Polano M, et al. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools[J]. Eur J Cancer, 2021, 15(5): 143-143.
[8]
Li J, Canseco D, Wang Y, et al. Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver[J]. Eur J Pharm Biopharm, 2021, 20(8): 158-158.
[9]
陈亚进, 周睿. 重视腹腔镜肝切除手术的安全性[J]. 中国实用外科杂志, 2022, 42(9): 5.
[10]
Didem KS, Hacer U, Gulcin N, et al. The effects of acupressure and yoga for coping with premenstrual syndromes on premenstrual symptoms and quality of life[J]. Complement Ther Clin Pract, 2021, 42:101282.
[11]
方迎兵, 戴贵森, 沈绍信. 以解剖性肝切除为基础的精准肝切除治疗肝胆恶性肿瘤的效果及并发症分析[J]. 中外医学研究, 2021, 19(30): 3.
[12]
Marques GF, Melro FIMB, Arthur JKP, et al. Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?[J]. Surg Oncol Clin North Am, 2021, 30(1): 102-104.
[13]
黄靖波, 刘亚晖, 李智, 等. 尾侧入路腹背侧联合显露肝中静脉在肝癌腹腔镜解剖性半肝切除中的应用[J]. 中华肝胆外科杂志, 2022, 28(3): 198-201.
[14]
Antoine C, Thomas D, Regis F. Robotic central hepatectomy for hepatocarcinoma by glissonean approach(with video)[J]. Surg Oncol, 2021, 40(12): 36-36.
[15]
王小波, 魏永刚. 基于三维重建与ICG荧光引导的腹腔镜下解剖性肝Ⅳ段切除术[J]. 中国普外基础与临床杂志, 2021, 28(12): 1632-1636.
[16]
Yan T, Hui W, Zhu S, et al. Carboxymethyl chitosan based redox-responsive micelle for near-infrared fluorescence image-guided photo-chemotherapy of liver cancer[J]. Carbohydr Polym, 2021, 41(11): 253-253.
[17]
Ouyang R, Cao P, Jia P, et al. Bistratal Au@Bi2S3 nanobones for excellent NIR-triggered/multimodal imaging-guided synergistic therapy for liver cancer[J]. Bioact Mater, 2021, 6(2): 48-50.
[18]
Wang H, Feng C, Lu M, et al. Integrative single-cell transcriptome analysis reveals a subpopulation of fibroblasts associated with favorable prognosis of liver cancer patients[J]. Transl Oncol, 2021, 14(1): 234-236.
[19]
Wang X, Fu XH, Qian ZL, et al. Non-invasive detection of biliary tract cancer by low-coverage whole genome sequencing from plasma cell-free DNA: A prospective cohort study[J]. Transl Oncol, 2021, 14(1): 102-104.
No related articles found!
阅读次数
全文


摘要